Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in RPRX — Royalty Pharma plc

CIK 1125816 Wheaton, IL
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$47,794,740
+$10,071,372 QoQ
Shares Held
852,412
+8.4% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#63
of 646 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. RPRX ranks #19 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 547,132 $341,158,687
2 INCY
Incyte Corp
 1,587,996 $180,015,226
3 CORT
Corcept Therapeutics Inc
 1,829,545 $159,078,937
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,179 $143,643,884
5 EXEL
Exelixis, Inc.
 2,543,353 $138,383,836
6 ALNY
Alnylam Pharmaceuticals, Inc.
 421,534 $126,894,380
7 KRYS
Krystal Biotech, Inc.
 324,900 $120,755,583
8 AXSM
Axsome Therapeutics, Inc.
 482,061 $117,994,070

All Filings in RPRX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $47,794,740 852,412
2026-03-31 $37,723,368 786,395
2025-12-31 $32,671,858 845,545
2025-09-30 $27,645,619 783,606
2025-06-30 $39,778,705 1,104,044
2025-03-31 $49,784,216 1,599,236
2024-12-31 $20,369,939 798,508
2024-09-30 $27,044,674 955,980
2024-06-30 $23,849,977 904,436
2024-03-31 $753,297 24,804
2023-12-31 $5,230,245 186,196
2023-09-30 $405,661 14,947
2023-03-31 $376,945 10,462
2022-12-31 $5,083,022 128,619
2022-09-30 $5,921,326 147,370
2022-06-30 $13,121,440 312,118
2022-03-31 $12,073,002 309,882
2021-12-31 $19,637,840 492,794
2021-09-30 $16,439,869 454,894
2021-06-30 $19,963,031 487,022
2021-03-31 $23,550,699 539,906
2020-12-31 $30,386,105 607,115